Sandoz announces launch of piperacillin and tazobactam for injection, a generic version of Zosyn
Sandoz anounced the launch of piperacillin and tazobactam for injection, a generic equivalent of Zosyn®,...
Sanofi-aventis Establishes Research Collaboration with Harvard University
Sanofi-aventis announced a research collaboration with Harvard University. The goal of the collaboration is to...
Bharat Biotech Announces Launched Indias First Cell-culture H1N1 Swine Flu Vaccine
Bharat Biotech announced the launch of India?s first indigenously developed cell culture H1N1 swine fluvaccine...
FDA approved Dr. Reddy’s ANDA for Lansoprazole delayed-release capsules
Dr. Reddy’s Laboratories announced that it will be launching Lansoprazole delayed-release capsules (15 mg and...
First HIV diagnostic assay Results Available in Less Than 50 Minutes
Ortho Clinical Diagnostics announced U.S. FDA approval of a diagnostic assay for the detection of...
Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
Cephalon, Inc.announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R)...
Bristol-Myers Squibb Completes Acquisition of ZymoGenetics, Inc.
Bristol-Myers Squibb Company announced that it has completed its previously announced acquisition of ZymoGenetics, Inc.....
BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX for Treatment...
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, announced that its...
AstraZeneca and PoZEN received approval for VIMOVO in Europe
AstraZeneca and POZEN Inc. today announced that VIMOVO (naproxen/ esomeprazole magnesium) 500/20 mg modified-release tablets...
Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
Bexion Pharmaceuticals announced that it has been awarded a $1.5M Phase II Small Business Innovation...